Morgan Stanley on Medtronic, Inc. (MDT): 'Positive signs, though slightly soft organic'
Tweet Send to a Friend
Morgan Stanley analyst Patrick Wood reiterated an Overweight rating and $107.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
